Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. (linkinghub.elsevier.com)

Authors: Klausen MK … Fink-Jensen A Journal: The Lancet Published: 2026-05-02 DOI: https://doi.org/10.1016/S0140-6736(26)00305-3